Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma

Clinical trial NCT04930536 · COMPLETED

Trial details

NCT number: NCT04930536
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma

Start date: 2021-07-14
Primary completion: 2023-05-02
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.